Drug Type Peptide Conjugate Radionuclide |
Synonyms 90Y-DOTA-D-Phe1-Tyr3-octreotide, OctreoTher, Onalta + [7] |
Target |
Mechanism SSTR agonists(Somatostatin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC65H89N14O18S2Y |
InChIKeyDUSFGVAHRFYHFD-IEOVAKBOSA-K |
CAS Registry189758-25-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
malignant carcinoid tumor of digestive tract | Phase 2 | - | 01 Jun 2008 | |
Neuroendocrine Tumors | Phase 2 | - | - | |
Neuroendocrine Tumors | Phase 2 | - | - |
Phase 2 | 39 | 68Ga-DOTATOC PET Positron Emission Tomography (PET) whole body scan+Amino Acids | mauzqlbocq(epffpnzglp) = evnpvqwasw mdjflxfxby (rpnbuvoyvn, wqgmedttdu - brjkdivmac) View more | - | 09 Feb 2023 | ||
Not Applicable | 60 | (4-cycle regimen) | bdwgxdbhff(lteswulxii) = xwjtkdtthq huujrrwnve (uzbkopqpdz, 38% less than baseline) View more | - | 15 Jul 2004 | ||
(single-cycle regimen) | bdwgxdbhff(lteswulxii) = xnnypxsble huujrrwnve (uzbkopqpdz, 27% less than baseline) View more |